Biosurgery Market Size, Share, Trends, Opportunity, And Forecast To 2033 | Baxter International Inc., B. Braun SE, Becton, Dickinson and Company, Hemostasis LLC

Overview and Scope

Biosurgery refers to the practice of using live maggots to remove dead tissue from wounds, reduce the risk of infection, and hasten wound healing. It primarily consists of semi-synthetic, synthetic, or natural materials that aid in the healing of surgical incisions and the restoration of tissue.

Sizing and Forecast

The biosurgery market size has grown strongly in recent years. It will grow from $14.01 billion in 2023 to $15.18 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing surgical procedures, rise in chronic diseases, growing geriatric population, shift towards biodegradable product, regulatory changes and approvals..

The biosurgery market size is expected to see strong growth in the next few years. It will grow to $20.87 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to advancements in tissue engineering, rise in minimally invasive procedures, focus on regenerative medicine, shift towards biologics, aging population needs.. Major trends in the forecast period include growth in minimally invasive procedures, rise in cosmetic and plastic surgeries, focus on stem cell therapies, advancements in wound care, development of biodegradable products..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/biosurgery-global-market-report

The biosurgery market covered in this report is segmented –

1) By Product: Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers, Staple Line Reinforcement
2) By Source: Natural or Biologics Products, Synthetic Products
3) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, Other Applications
4) By End-User: Hospitals, Clinics, Other End-Users

North America was the largest region in the biosurgery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the biosurgery market report during the forecast period. The regions covered in the biosurgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=9380&type=smp

Major Driver Impacting Market Growth

The increase in the prevalence of chronic disease is expected to propel the growth of the biosurgery market going forward. Chronic disease refers to health problems that persist for a year or longer and necessitate continuing medical care, restricting everyday activities, or both. The main causes of death and disability in the US are chronic diseases such as diabetes, cancer, and heart disease. Biosurgery is used to eliminate dead tissue, lower the risk of infection, and speed up the healing process for chronic wounds. For instance, in March 2022, according to the Australian Bureau of Statistics, an Australia-based self-contained legal agency responsible for collecting and analyzing data as well as making evidence-based recommendations to federal, state, and territory governments, seventy-eight percent (78.6%) of Australians suffered from at least one chronic illness. 11.6 million individuals, or over half of the population, suffered from at least one chronic illness. Therefore, the increase in the prevalence of chronic disease is driving the growth of the biosurgery market.

Key Industry Players

Major companies operating in the biosurgery market are adopting a strategic partnership approach to expand capabilities in the market. Strategic partnerships refer to a process in which companies leverage each other’s strengths and resources to achieve mutual benefits and success. For instance, in March 2022, Biocomposites Ltd., a UK-based manufacturing company of calcium compound solutions for bone and soft tissue regeneration and repair, announced an agreement with Zimmer Biomet Holdings Inc. to exclusively sell genex Bone Graft Substitute in the US orthopedic market, with its unique mixing mechanism and delivery choices. The genex Bone Graft Substitute is a biphasic composite of excellent purity that has been precisely developed to equalize osteoconductive scaffold toughness and persistence in the body to allow for optimum bone architecture rebuilding. Genex has been improved for the US market as part of the new arrangement, including a new closed-mixing method to save preparation time and increase working time. It also features a more extensive set of delivery options, allowing a surgeon to inject, shape, or prepare beads using their preferred approach.

The biosurgery market report table of contents includes:

1. Executive Summary

2. Biosurgery Characteristics

3. Biosurgery Trends And Strategies

4. Biosurgery – Macro Economic Scenario

5. Global Biosurgery Size and Growth

…..

32. Global Biosurgery Competitive Benchmarking

33. Global Biosurgery Competitive Dashboard

34. Key Mergers And Acquisitions In The Biosurgery

35. Biosurgery Future Outlook and Potential Analysis

36. Appendix